Avant Bio Fund II LP — Form D/A
Avant Bio Fund II LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2024-12-23. $57.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-12-23
- Form: D/A
- Accession: 0001972528-24-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $57.5M
- Investors: 12
- Date of first sale: 2023-05-12
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-490156
Issuer
- Name: Avant Bio Fund II LP
- CIK: 0001972528
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: PENN 1, NEW YORK, NY, 10119
- Phone: 201-562-7927
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Daniella Kranjac | Director | New York, NY |
Other filings by this issuer (1)
More